1min
Oct 19, 2023
Are we living in the "Golden Age of Medicine"? That's what the New York Times just proposed. Between CRISPR-powered therapies, mRNA applications, and other biotech advancements, we have remarkably effective treatments for everything from breast cancer to obesity in final approval stages, and experts say that this may be just the beginning.
These breakthroughs could transform our life expectancy expectations, and drive an unprecedented dependence on excellent financial decision-making.
In this 45-minute webinar, we brought together longevity and financial experts for this special session on the implications of this Medical Golden Age.
Watch the replay
Interested in becoming a Savvly founding investor?
For a limited time, Savvly investors who get in early can receive benefits, including no early withdrawal fees within the first two years of investing — for all future contributions, for life. Think of this as a free test drive for two years. Learn more here.
